Phase 1 Trial of Vaccination With Autologous Tumor Cells and Antisense Directed Against the Insulin Growth Factor Type 1 Receptor (IGF-1R AS ODN) in Patients With Recurrent Glioblastoma

JHN Journal
doi 10.29046/jhnj.013.1.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Thomas Jefferson University


Related search